Zymeworks authorizes $200 million share buyback program
ZYME•Zymeworks authorized a second 2026 share repurchase program covering up to $200 million of common stock through 2028. Repurchases are expected to begin before year-end, with approximately $140 million in spending planned through 2028; its initial program, authorizing up to $125 million, is complete.




